Literature DB >> 18066063

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

Lao H Saal1, Sofia K Gruvberger-Saal, Camilla Persson, Kristina Lövgren, Mervi Jumppanen, Johan Staaf, Göran Jönsson, Maira M Pires, Matthew Maurer, Karolina Holm, Susan Koujak, Shivakumar Subramaniyam, Johan Vallon-Christersson, Håkan Olsson, Tao Su, Lorenzo Memeo, Thomas Ludwig, Stephen P Ethier, Morten Krogh, Matthias Szabolcs, Vundavalli V V S Murty, Jorma Isola, Hanina Hibshoosh, Ramon Parsons, Ake Borg.   

Abstract

Basal-like breast cancer (BBC) is a subtype of breast cancer with poor prognosis. Inherited mutations of BRCA1, a cancer susceptibility gene involved in double-strand DNA break (DSB) repair, lead to breast cancers that are nearly always of the BBC subtype; however, the precise molecular lesions and oncogenic consequences of BRCA1 dysfunction are poorly understood. Here we show that heterozygous inactivation of the tumor suppressor gene Pten leads to the formation of basal-like mammary tumors in mice, and that loss of PTEN expression is significantly associated with the BBC subtype in human sporadic and BRCA1-associated hereditary breast cancers. In addition, we identify frequent gross PTEN mutations, involving intragenic chromosome breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient tumors. These data provide an example of a specific and recurrent oncogenic consequence of BRCA1-dependent dysfunction in DNA repair and provide insight into the pathogenesis of BBC with therapeutic implications. These findings also argue that obtaining an accurate census of genes mutated in cancer will require a systematic examination for gross gene rearrangements, particularly in tumors with deficient DSB repair.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066063      PMCID: PMC3018354          DOI: 10.1038/ng.2007.39

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

1.  Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).

Authors:  Johan Staaf; Therese Törngren; Eva Rambech; Ulla Johansson; Camilla Persson; Gunilla Sellberg; Lina Tellhed; Mef Nilbert; Ake Borg
Journal:  Hum Mutat       Date:  2008-04       Impact factor: 4.878

Review 2.  Homologous repair of DNA damage and tumorigenesis: the BRCA connection.

Authors:  Maria Jasin
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Authors:  N Loman; O Johannsson; U Kristoffersson; H Olsson; A Borg
Journal:  J Natl Cancer Inst       Date:  2001-08-15       Impact factor: 13.506

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Heterotransplantation of human malignant tumors in "nude" thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors.

Authors:  B C Giovanella; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

7.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

8.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

9.  BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.

Authors:  Lao H Saal; Carl Troein; Johan Vallon-Christersson; Sofia Gruvberger; Ake Borg; Carsten Peterson
Journal:  Genome Biol       Date:  2002-07-15       Impact factor: 13.583

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  170 in total

Review 1.  Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Authors:  Nuria Rodríguez Salas; Enrique González González; Carlos Gamallo Amat
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

Review 2.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

3.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

4.  PTEN regulates PLK1 and controls chromosomal stability during cell division.

Authors:  Zhong Zhang; Sheng-Qi Hou; Jinxue He; Tingting Gu; Yuxin Yin; Wen H Shen
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

5.  PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.

Authors:  Howard M Stern; Humphrey Gardner; Tomasz Burzykowski; Wafaa Elatre; Carol O'Brien; Mark R Lackner; Gary A Pestano; Angela Santiago; Ivonne Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Paolo Nuciforo; Valerie Bee; John Mackey; Dennis J Slamon; Michael F Press
Journal:  Clin Cancer Res       Date:  2015-02-03       Impact factor: 12.531

6.  TIPIN depletion leads to apoptosis in breast cancer cells.

Authors:  Céline Baldeyron; Amélie Brisson; Bruno Tesson; Fariba Némati; Stéphane Koundrioukoff; Elie Saliba; Leanne De Koning; Elise Martel; Mengliang Ye; Guillem Rigaill; Didier Meseure; André Nicolas; David Gentien; Didier Decaudin; Michelle Debatisse; Stéphane Depil; Francisco Cruzalegui; Alain Pierré; Sergio Roman-Roman; Gordon C Tucker; Thierry Dubois
Journal:  Mol Oncol       Date:  2015-05-09       Impact factor: 6.603

7.  Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.

Authors:  Triparna Ghosh-Choudhury; Chandi C Mandal; Kathleen Woodruff; Patricia St Clair; Gabriel Fernandes; Goutam G Choudhury; Nandini Ghosh-Choudhury
Journal:  Breast Cancer Res Treat       Date:  2008-10-26       Impact factor: 4.872

8.  Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

Authors:  Norazizah Shafee; Christopher R Smith; Shuanzeng Wei; Yoon Kim; Gordon B Mills; Gabriel N Hortobagyi; Eric J Stanbridge; Eva Y-H P Lee
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.

Authors:  Mari Gasparyan; Miao-Chia Lo; Hui Jiang; Chang-Ching Lin; Duxin Sun
Journal:  J Biol Chem       Date:  2020-05-28       Impact factor: 5.157

10.  Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.

Authors:  Nathalie Dourdin; Babette Schade; Robert Lesurf; Michael Hallett; Robert J Munn; Robert D Cardiff; William J Muller
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.